Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Swissmedic approves the use of the Janssen COVID-19 vaccine as a booster dose for people over the age of 18 years, which can be administered two months after the first dose

Swissmedic approves the use of the Janssen COVID-19 vaccine as a booster dose for people over the age of 18 years, which can be administered two months after the first dose, or six months after a person receives mixed vaccinations with mRNA-based vaccines.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthSwissmedic approves the use of the Janssen COVID-19 vaccine as a booster dose for people over the age of 18 years, which can be administered two months after the first dose

Swissmedic approves the use of the Janssen COVID-19 vaccine as a booster dose for people over the age of 18 years, which can be administered two months after the first dose, or six months after a person receives mixed vaccinations with mRNA-based vaccines.

View Premium plansBrowse free archive reports